S+SeqTrial

$B$9$Y$F8GDj$5$l$?I8K\7W2h$G$O!"%W%i%;%\$KBP$7$F;n83Lt$N<#NE8z2L$,Bg$-$/$F$b!"ITL@NF$G$b!"5U$KM-32$G$b!"EPO?45c$7!";q8;$rM-8zMxMQ$9$k$?$a$KCf4V2r@O$,$h$/9T$o$l$k$h$&$K$J$j$^$7$?!#(B

$BC`5G'$J$I$NNQM}E*$J9MN8$,$3$l$i$N;n83$GI,MW$H$5$l$k$+$i$G$9!#)$7$F$$$^$9!#(B

$B8GDjI8K\$G$N4pK\35G0!];n83$N%5%$%:!"8!=PNO!">INc?t$rL@3N$K$9$k$3$H!]$O!"72C`INc?t$,#1$D$N8GDj$5$l$??t;z$G$O$J$$$H$$$&$3$H$G$9!#$=$NBe$o$j!"E,@Z$J7W2h$K4p$E$$$F9T$o$l$?Cf4V2r@O$N7k2L$+$i;n83$rAa4|$KCf;_$9$Y$-$+$I$&$+$H$$$&Cf;_5,Dj(B(stopping rules)$B$r$I$&7h$a$k$+$,>GE@$H$J$C$F$-$^$9!#$3$N$?$a!"72C`/$5$;$k$3$H$,$G$-!"NW>2;n83$NNQM}LL$H8zN(LL$,8~>e$5$l$?;n83$H8@$($k$G$7$g$&!#(B

$B

S+SEQTRIAL$B$G72C`

$B$3$NNc$O!"Bh-7Aj;n83$N5^@-9|?q@-Gr7lIB$N45]45Z$9$k$3$H$G$9!#(B

$B#22s$NCf4V2r@O$rH<$&72C`INc?t$O3F72(B90$B?M$G$9!#?^(B1.1$B$N:8OH$O72C`!$C$F$$$k$+!"$"$k$$$O!"Nt$C$F$$$k$+$rCf4V2r@O$,<($7$?>l9g$O!";n83$,Cf;_$5$l$^$9!#Cf4V2r@O$+$iM%Nt$,L@3N$K$5$l$J$+$C$?>l9g$O!";n83$,:G8e$^$GB39T$5$l!"?7Lt$,M%$l$F$$$k$N$+!"Nt$C$F$$$k$N$+!"$I$A$i$NLt$,NI$$$N$+H=Dj$G$-$J$$$N$+$,:G=*2r@O$G<($5$l$^$9!#!JNW>2E*$K=EMW$H$5$l$k:9$N:G>.CM$K$b$h$j$^$9$,!"$I$A$i$NLt$,NI$$$N$+H=Dj$G$-$J$$>l9g$O$[$\F1Ey$N8z2L$@$H$$$&$3$H$G$7$g$&!K(B

$B?^(B1$B!'5^@-9|?q@-Gr7lIB$KBP$9$k?7Lt$HI8=`Lt$N422rN((B(the rate of complete remission)$B$N:9$rZ$9$k$3$H$rL\E*$H$9$k72C`

$B?^(B1$B$N1&OH$K$OF10l%5%$%:$GF1$88!=PNO$r$b$D8GDjI8K\$N>l9g$,<($5$l$F$$$^$9!#8GDjI8K\$G$O3F72Ls(B88$B?M$N>INc?t$,I,MW$G$9!#$3$l$KBP$7!"72C`l9g$KI,MW$J>INc?t$O3F72(B90$B?M$G$9!#(B

$B72C`$l(B78$B!s$H(B56$B!s$G$7$?!#N>

$B?^(B2$B!':8?^!'72C`INc?t!J(BASN$B!K!#F1$88!=PNO$r$b$D8GDjI8K\$h$j$b

$B?^(B2$B$O72C`INc?t!J(BASN$B!K$H8!=PNO6J@~$r<($7$?$b$N$G$9!#;n83$N%5%$%:$H8!=PNO$OF1$8$G$9!#8GDjI8K\$G$O(B90$B?M$N45INc?t$O8GDjI8K\$h$j$b>/$J$/$F:Q$_$^$9!#/$J$$J?6Q>INc?t$K$J$C$F$$$^$9(B($B?^(B1.2$B;2>H(B)$B!#$3$N8!=PNO$K$*$1$k8zN($NA}2C$O4pK\E*$K%3%9%H$r$+$1$k$3$H$J$7$KI=$l$^$9!#$D$^$j!"72C`

S+SeqTrial$B$NMQES(B

$BCf4V2r@O(B(interim analyses)$B$r9T$&FqE@$OFCH(B)$B!#@_Dj$7$?Bh-5

$B$^$?!"%=%U%H$O!":GE,$J72C`2A$r9T$&$N$K$bI,MW$G$9!#8GDjI8K\$HHf$Y$k$H!"72C`2;n83$O=@Fp$JE,1~@-$rHw$($?7W2h$H$J$C$F$$$^$9!#7W2h%Q%i%a!<%?!<$K$O8!=PNO$d>INc?t$@$1$G$J$/!"0J2<$N9`L\$b4^$^$l$^$9!#(B

• $B2r@O2s?t$H2r@O;~4|(B
• $B7W2h$N8zN((B
• $BAa4|Cf;_4p=`!J5"L52>@b!"BPN)2>@b!"$"$k$$$ON>$BCY$$;~E@$N2r@O$KBP$7Aa$$;~E@$N2r@O$G;n83$r=*N;$9$k$3$H$NAjBPE*$JMF0W@-$^$?$OJ]

  S+SEQTRIAL$B$G$O:GE,$N7W2h$rA*$V$3$H$,2DG=$G$9!#(B

  $B$?$@$7!"(BS+SEQTRIAL$B$G$ODj$7$F$$$^$9!#<#NE8z2L!JH?1~!K$O8!DjE}7WNL$GI>2A$5$l$F$$$k$3$H!#$^$?!"$3$N8!DjE}7WNL$O$[$\I8=`@55,J,I[$K=>$&$3$H!J8GDjI8K\$K$D$$$F$O!K!#$5$i$K!"O"B3$7$?2r@O4V$K2C$o$k>pJs$OFHN)$7$?>pJs$H9gM}E*$K8+$J$7$F$h$$$3$H!#BgItJ,$NNW>2;n83$,$3$N$h$&$J8!Dj$K4p$E$$$F$$$k$3$H$G$9!#(B

  

  $B?^(B3$B!'8!DjE}7WNL$KBP$9$kE57?E*$JI8K\L)EY4X?t!#8GDjI8K\(B($B:8(B)$B$H72C`

  S+SeqTrial$B$N5!G=FCD'(B

  S+SEQTRIAL$B$O7W2h!"%b%K%?%j%s%0!"2r@O$J$INW>2;n83$re$G$NA4$F$N%U%'!<%:$G3hMQ$G$-$^$9!#0J2<$,

  $B40A4$J%=%U%H4D6-(B

  S+SEQTRIAL$B$O!"72C`

  • $BFC2=$5$l$?%*%V%8%'%/%H!J7W2h!"6-3&!"2>@b$J$I!K$H%a%=%C%I!JA`:n$NFC@-$d8!=PNO6J@~%W%m%C%H$J$I!K$r$b$D!"40A4$J%*%V%8%'%/%H;X8~7?8@8l$G$9!#(B
  • $BDL>o$N2r@O$KMQ$$$i$l$k(BS-PLUS$B8@8l$HE}9g$7!"I,MW$K1~$8$F2r@O$r%+%9%?%^%$%:$7(BS+SEQTRIAL$B3HD%HG$r:n$k$3$H$,$G$-$^$9!#(B
  • $BNW>2$HE}7W$NN>46E*$+$D;k3PE*$J%f!<%6!<%$%s%?!<%U%'!<%9!J%&%$%s%I%&%:HG$N$_!K$G$9!#(B
  • $BFCDj$N2r@O$KBP$9$kB?$/$NDc$B8zN($h$/Dj5A$5$l$?%S%k%G%#%s%0!&%V%m%C%/$r;}$D!"%*!<%W%s%=%U%H%&%(%"%G%6%$%s$G$9!#(B
  • $B6-3&!"8!=PNO6J@~!"J?6Q>INc?t!J(BASN$B!K6J@~!"Cf;_3NN($rMF0W$KHf3S$G$-$k$h$&$3$l$i$r%W%m%C%H$G$-$^$9!#(B
  • $BI8K\J?6Q!"#zE}7WNL!"8GDjI8K\$N(Bp$BCM!"ItJ,9g7W!"%(%i!<>CHq4X?t!"%Y%$%9N.$N;v8eJ?6Q$H>r7oIU3NN($HM=B,3NN($J$I$N6-3&$N%9%1!<%k$r%f!<%6!<$,A*Br$G$-$^$9!#(B
  • $B6/NO$J(BTrellis$B%0%i%U%7%9%F%`$K$h$k

    $BCf;_5,Dj$N7W;;(B

    S+SEQTRIAL$B$G$O0J2<$N$h$&$J$5$^$6$^$JCf;_5,Dj$r7W;;$9$k5;=Q$rDs6!$7$^$9!#(B

    • $BE}0l$5$l$?72C`$B?7$7$/0lHL2=$5$l$?7W2hB2!#(BS+SEQTRIAL$B$O$3$N?7$7$$7W2h$K$D$$$FE}0l$5$l$?%Q%i%a%?!<2=(B(parameterization)$B$rHw$($F$$$^$9!#$3$l$h$j!"7W2h$NA*Br$,MF0W$K$J$j!"3NN(E*$K@Z$j5M$a$?>r7oIU8!=PNO$dM=B,$B%"%W%j%1!<%7%g%s$K$O!"@55,J,I[!"#29`J,I[!"%]%"%=%sJ,I[!"@8B8;~4V!"#1I8K\$H#2I8K\$,4^$^$l$F$$$^$9!#(B
    • $BJRB&8!Dj!"N>B&8!Dj!"F1Ey@-8!Dj$H?7$7$$%O%$%V%j%C%I8!Dj$,$"$j$^$9!#(B
    • Lan & DeMets(1989)$B$H(BPampallona ,Tsiatis & Kim(1993)$B$K$h$k%(%i!<>CHq4X?t$rFCDj$9$k$3$H$,$G$-$^$9!#(B
    • $BI8K\J?6Q!"#zE}7WNL!"8GDjI8K\$N#pCM!"ItJ,OB!"%(%i!<>CHq4X?t!"%Y%$%:N.$N;v8eJ?6Q!">r7oIU$-M=B,3NN($J$I$GG$0U$N6-3&$r@_Dj$G$-$^$9!#(B
    • $B@53N$J6-3&$O?tCM@QJ,$+$i;;=P$7$^$9!#(B

    $B7W2h$NI>2A(B

    S+SEQTRIAL$B$K$O7W2h$rI>2A$9$k$5$^$6$^$J5;=Q$,4^$^$l$F$$$^$9!#(B

    • $B8!=PNO6J@~(B
    • $B:GBg>INc?t$N7W;;(B
    • $B>INc?t$NJ,I[!'J?6Q>INc?t6J@~$H;MJ,0LE@6J@~(B
    • $BCf;_3NN((B
    • $B>r7oIU$-8!=PNO(B
    • $B6-3&$G$NE}7WE*?dB,(B
    • $B%Y%$%:E*FC@-!JI8=`$N;vA0J,I[!K(B

    $BNW>2;n83$N%b%K%?%j%s%0(B

    S+SEQTRIAL$B$O$5$^$6$^$J%b%K%?%j%s%05;=Q$rDs6!$7$^$9!#(B

    • Lan & DeMets(1989)$B$H(BPampallona ,Tsiatis & Kim(1993)$B$K$h$k@53N%(%i!<>CHq4X?t(B
    • Kittelson & Emerson(1999)$B$K$h$kE}0l$5$l$?72C`$B3NN($K4p$E$/;n83BG$A@Z$jK!(B

    $B2r@O$H7k2L$N2r

    S+SEQTRIAL$B$G$O$5$^$6$^$J2r@O$d7k2L$N2r

    • $B7P;~$K4p$E$$$??dB,(B(Tsiatis, Rosner & Mehta,0984)$B$HI8K\J?6Q=g$K4p$E$$$??dB,(B(Emerson & Fleming, 1990)
    • $B@53N#pCM(B
    • $B@53N?.Mj6h4V(B
    • $BCf;_5,Dj$+$iD4@0$7$?E@?dDj!'%P%$%"%9$rD4@0$7$?J?6Q(B(Whitehead, 1986)$B!"ITJPCf1{CM$N?dDj!"0lMM:G>.J,;6ITJP?dDjNL(B(UMVUE)
    • $B%Y%$%:E*;v8e?dB,!JI8=`$N;vA0J,I[!K(B

    $B;29M;qNA(B

    S+SeqTrial Technical Overview$B!J1Q8l!"(BPDF$B!K(B

    S+SeqTrial$B$N$49XF~$K$D$$$F(B

    S-PLUS for Windows V6.1 $B0J>e$KBP1~$7$F$$$^$9!#(B

    S+SeqTrial$B$N2A3J!"9XF~J}K!$K$D$$$F$O!"3t<02q